Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 71 citing articles:

A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
Jeffrey West, Fred Adler, Jill Gallaher, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 43
Stackelberg evolutionary game theory: how to manage evolving systems
Alexander Stein, Mónica L. Salvioli, Hasti Garjani, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1876
Open Access | Times Cited: 30
Treatment of evolving cancers will require dynamic decision support
Maximilian Strobl, Jill Gallaher, Mark Robertson‐Tessi, et al.
Annals of Oncology (2023) Vol. 34, Iss. 10, pp. 867-884
Open Access | Times Cited: 23
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy
Kit Gallagher, Maximilian Strobl, Derek S. Park, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1929-1941
Open Access | Times Cited: 11
The evolutionary theory of cancer: challenges and potential solutions
Lucie Laplane, Carlo C. Maley
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 718-733
Closed Access | Times Cited: 11
Applications of Artificial Intelligence in Prostate Cancer Care: A Path to Enhanced Efficiency and Outcomes
Irbaz Bin Riaz, Stephanie A. Harmon, Zhijun Chen, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy
Maximilian Strobl, Alexandra Martin, Jeffrey West, et al.
Cell Systems (2024) Vol. 15, Iss. 6, pp. 510-525.e6
Closed Access | Times Cited: 7
Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
Youcef Derbal
Clinical Medicine Insights Oncology (2025) Vol. 19
Open Access
Validation of polymorphic Gompertzian model of cancer through in vitro and in vivo data
Arina Soboleva, Artem Kaznatcheev, Rachel Cavill, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0310844-e0310844
Open Access
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis
Thierry Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.
Trends in cancer (2025)
Open Access
Spatio-temporal model of combining ADT and chemotherapy with senolytic treatment in metastatic prostate cancer
Teddy Lazebnik, Avner Friedman
Journal of Theoretical Biology (2025) Vol. 602-603, pp. 112069-112069
Closed Access
Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy
Kenneth J. Pienta, Patrick L. Goodin, Sarah R. Amend
CA A Cancer Journal for Clinicians (2025)
Open Access
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
Sravani Ramisetty, Prakash Kulkarni, S. Bhattacharya, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 599-599
Open Access | Times Cited: 14
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties
Maisa N.G. van Genderen, Jeroen Kneppers, Anniek Zaalberg, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease
Ryan T. Bishop, Anna Miller, Matthew Froid, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
N-of-1 medicine
Peter Wang, Qiao Ying Leong, Ni Yin Lau, et al.
Singapore Medical Journal (2024) Vol. 65, Iss. 3, pp. 167-175
Open Access | Times Cited: 4
Conditional success of adaptive therapy: the role of treatment-pausing thresholds revealed by mathematical modeling
Lanfei Sun, Haifeng Zhang, Kai Kang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial
Agata Blasiak, Anh T. L. Truong, Nigel Foo, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling
Maximilian Strobl, Alexandra Martin, Jeffrey West, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers
Jad Chahoud, Alexander R.A. Anderson, Jingsong Zhang, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 28, pp. 4469-4471
Open Access | Times Cited: 10
Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer
Helen Hockings, Eszter Lakatos, Weini Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Adaptive Control of Tumor Growth
Youcef Derbal
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 3
Tumor containment: a more general mathematical analysis
Frank Ernesto Alvarez, Yannick Viossat
Journal of Mathematical Biology (2024) Vol. 88, Iss. 4
Open Access | Times Cited: 3
A Continuation Technique for Maximum Likelihood Estimators in Biological Models
Tyler Cassidy
Bulletin of Mathematical Biology (2023) Vol. 85, Iss. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top